Trials / Recruiting
RecruitingNCT06186882
Gene x Environment Interplay in Developmental Dyslexia Treatment: A Round-trip Translation Between Humans and Animal
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- IRCCS Eugenio Medea · Academic / Other
- Sex
- All
- Age
- 5 Years – 6 Years
- Healthy volunteers
- Accepted
Summary
Developmental dyslexia affects 7% of school-age children (Male:Female ratio of 1.5:1) and incurs disadvantages in education and occupation. Scientific progress concerning the etiology of developmental dyslexia evidenced the complex gene-environment interaction. The DCDC2-READ1 deletion associates with reading skills and affects the magnocellular-dorsal stream in humans and animals. DCDC2 modifies neural activity within the excitatory pathways. The magnocellular-dorsal stream mediates the function of the attention network. Difficulties in spatial and temporal attention shifting impair letter-to-speech sound integration increasing neural noise. Action video games improve the efficiency of the magnocellular-dorsal stream. The aim of this cutting-edge, round trip translation study is threefold: 1.to unravel new insights behind the pathophysiology of developmental dyslexia, 2. to assess gene-environment interaction effects on developmental dyslexia endophenotypes, and 3. to identify useful clues to foster the identification of new, personalized treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Action Video-Game | Thanks to their specific characteristics (presentation of multiple peripheral, rapidly moving, spatio-temporally unpredictable stimuli), Action Video-Games improve reading skills through their effects on the Magnocellular-Dorsal stream. Training will consist of 20 days of Action Video-Games sessions of 1 hour each, three times per week. |
Timeline
- Start date
- 2023-04-30
- Primary completion
- 2026-04-30
- Completion
- 2026-04-30
- First posted
- 2024-01-02
- Last updated
- 2024-01-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06186882. Inclusion in this directory is not an endorsement.